LDR | |
01124nam a2200313 a 4500 |
001 |
|
010597698 |
003 |
|
MiAaHDL |
005 |
|
20101005000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
890627m19909999wb a b 00100 eng c |
010 |
⊔ |
⊔ |
‡a 89011530
|
020 |
⊔ |
⊔ |
‡a0387511822 (v. 1 : U.S. alk. paper)
|
035 |
⊔ |
⊔ |
‡asdr-nwu170186
|
035 |
⊔ |
⊔ |
‡9AEV5318HS
|
040 |
⊔ |
⊔ |
‡aDNLM/DLC
‡cDLC
‡dDLC
|
050 |
0 |
0 |
‡aQP905
‡b.H3 vol. 94
‡aRC268.5
|
060 |
⊔ |
⊔ |
‡aW1 HA51L v. 94
‡aQZ 202 C5174
|
082 |
0 |
0 |
‡a615/.1 s
‡a616.99/4071
‡219
|
245 |
0 |
0 |
‡aChemical carcinogenesis and mutagenesis /
‡ccontributors, F.A. Beland ... [et al.] ; editors, C.S. Cooper and P.L. Grover.
|
260 |
0 |
⊔ |
‡aBerlin ;
‡aNew York :
‡bSpringer-Verlag,
‡cc1990-
|
300 |
⊔ |
⊔ |
‡av. :
‡bill. (some col.) ;
‡c25 cm.
|
490 |
⊔ |
0 |
‡aHandbook of experimental pharmacology ;
‡vv. 94
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographies and index.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aMutagens.
|
650 |
⊔ |
2 |
‡aCarcinogens.
|
650 |
⊔ |
0 |
‡aMutagens.
|
650 |
⊔ |
0 |
‡aChemical mutagenesis.
|
650 |
⊔ |
0 |
‡aCarcinogens.
|
650 |
⊔ |
0 |
‡aCarcinogenesis.
|
700 |
1 |
0 |
‡aGrover, Philip L.
|
700 |
1 |
0 |
‡aCooper, C. S.
‡q(Colin S.),
‡d1954-
|
700 |
1 |
0 |
‡aBeland, F. A.
‡q(Frederick A.)
|
CID |
⊔ |
⊔ |
‡a010597698
|
DAT |
0 |
⊔ |
‡b20101005000000.0
|
DAT |
1 |
⊔ |
‡a20120815041604.0
‡b2023-09-09T17:40:25Z
|
DAT |
2 |
⊔ |
‡a2023-09-09T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-NWU
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-nwu170186
‡aien
‡bSDR
‡cNWU
‡pien.35558001850433
‡sIEN
‡zv.2
‡1170186
|
974 |
⊔ |
⊔ |
‡bIEN
‡cNWU
‡d20230909
‡sgoogle
‡uien.35558001850433
‡zv.2
‡ric
‡qbib
‡tnon-US bib date2, date type m >= 1929
|